Skip to main content

Table 4 Estimation of lives saved by DOTS case detections and treatments in Global Fund-supported programs, cumulatively between 2003 and December 2007.

From: Lives saved by Global Fund-supported HIV/AIDS, tuberculosis and malaria programs: estimation approach and results between 2003 and end-2007

Region Countries with GF-supported DOTS programme Case detections in GF-supported DOTS programmes Estimate d treatments completed Cumulative lives saved (95% UR)
     Counterfactual scenario: Counterfactual scenario:
     No treatment Non-DOTS treatment
East Africa 7 448,243 363,794 223,574 (128,704-318,445) 76,019 (42,182-109,856)
Western Africa 10 109,806 87,668 53,692 (31,794-75,591) 18,205 (10,396-26,015)
Southern Africa 6 239,144 208,153 133,546 (75,230-191,862) 46,957 (25,593-68,320)
North Africa & Middle East 9 68,195 45,438 26,634 (15,708-37,560) 6,342 (2,912-9,772)
Eastern Europe & Central Asia 10 72,345 53,023 26,125 (15,558-36,691) 1,530 (370-2,690)
South Asia 7 554,726 382,333 230,612 (133,671-327,553) 75,654 (41,271-110,037)
East Asia and the Pacific 9 1,774,876 1,524,979 916,232 (541,056-1,291,408) 180,256 (94,065-266,448)
Latin America & Caribbean 10 44,926 35,418 21,205 (12,588-29,823) 3,182 (1,620-4,743)
Total 68 3,312,261 2,700,805 1,632,000   408,000  
   95% Uncertainty range   (3,211,843 -3,412,679) (2,618,925 -2,782,685) (1,094,000-2,169,000) (265,000-551,000)
  1. DOTS results are from country reports to Global Fund secretariat. Table excludes a multi-country grant in the Western Pacific. Country groupings, including certain regions, are as per the Global Fund regional categorizations http://www.theglobalfund.org. Country-specific assumptions on proportions of smear-positive TB cases that are HIV-infected, and case fatality rates with and without DOTS were provided by the WHO Stop TB department (unpublished data).